RF Investment Partners, a provider of flexible growth capital, announces its platform investment in Altro and Amici Pharmaceuticals, a complementary pair of founder-owned companies that provide strategic sourcing, market insights, and production of generic pharmaceuticals for the growing companion pet and animal end markets. This strategic investment marks RF’s expansion in the healthcare sector as it enters the veterinary and pet-focused pharmaceutical space. 

Read the full press release here.